Anti-TNF therapies: a comprehensive analysis of adverse effects associated with immunosuppression

Victoria Connor (1)

1 University of Liverpool

Knowledge and understanding about the immunosuppressive properties of anti-TNF therapies and the adverse effects these causes have advanced over the last 10 years since the first of these drugs was approved. These drugs work by inhibiting tumour necrosis factor (TNF) in the body, which plays an essential role in the immune response to invading pathogens. Anti-TNF drugs have therapeutic value because high levels of TNF are thought to be part of the pathophysiology of many chronic inflammatory disorders such as rheumatoid arthritis and Crohn's disease. Anti-TNF drugs are usually well-tolerated, however, there have been reports of many potentially serious adverse effects. This article will comprehensively analyse these adverse effects; the incidence, symptoms and mechanisms will be discussed. In addition, the contraindications of this class of drugs will be explored and the detection and prevention methods that should be put in place by health care professionals who treat patients on these drugs will be described.

Mots clés: Anti-TNF; Biologics; Immunosuppresion; Adverse effects; Rheumatology

Victoria Connor. Anti-TNF therapies: a comprehensive analysis of adverse effects associated with immunosuppression. Rheumatology International, 2009, 31 (3), pp.327-337. ⟨10.1007/s00296-009-1292-x⟩. ⟨hal-00568316⟩